Drugs / ADRCs
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT00442806 | Nov 2007 → Apr 2012 | arteriosclerosis disorder, coronary artery disorder, myocardial infarction | Cytori Therapeutics | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT07360808 | Dec 2025 → Dec 2027 expected | pronation-supination of the forearm, impairment of, systemic sclerosis | Cytori Therapeutics | Recruiting | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT01216995 Comparator | Sep 2012 → May 2014 | acute myocardial infarction | Cytori Therapeutics | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ADRCs | “The experimental group will receive ADRCs, prepared from the Celution system, which is injected into specific sites on each finger of both hands.” NCT07360808 ↗2“Adipose Derived Regenerative Cells (ADRCs) Delivered Via the Intracoronary Route” NCT01216995 ↗ |
| Known as | Adipose-Derived Stem and Regenerative Cells | “The purpose of this study is to establish safety and feasibility of utilizing Adipose-Derived Stem and Regenerative Cells (ADRC's) in patients who have suffered a ST-elevation...” NCT00442806 ↗ |
| Modality | Cell therapy | “utilizing Adipose-Derived Stem and Regenerative Cells (ADRC's)” NCT00442806 ↗ |
| Route | Other | “ADRCs delivered via the intracoronary route” NCT01216995 ↗ |